⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2016Oncology Research and Treatment

Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials

Fengxia Chen Feifei Pu

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Denosumab was safer in delaying or preventing skeletal-related events in patients with bone metastases and prevented pain progression compared to ZA in this meta-analysis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2016) studied this question.

synapsesocial.com/papers/69d96b885e5bcb4e3b8365ed https://doi.org/10.1159/000447372

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone MetastasesOriginal Research · 2006 · 539 citations
2The Cost of Treatment of Skeletal-Related Events in Patients with Bone Metastases from Lung CancerRetrospective Study · 2004 · 155 citations
3Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumorsRCT · 2004 · 706 citations
4Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug managementObservational Study · 2007 · 459 citations
5Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous BisphosphonatesRCT · 2009 · 533 citations
6Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyRCT · 2010 · 1,598 citations
7Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple MyelomaRCT · 2011 · 1,265 citations
8Measuring inconsistency in meta-analyses2003 · 63,796 citations
9The risk of radiotherapy toxicity in patients with laryngeal cancer: predictive factors and radiobiological modellingOncology Research and Treatment · 2026
10Case Report: Dose dependent intracranial response to sotorasib in KRASG12C-mutated lung cancer brain metastasesOncology Research and Treatment · 2026

More from Oncology Research and Treatment

More from Huazhong University of Science and Technology

More from Union Hospital